The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Sex and Racial Differences in Pharmacological Response: Where Is the Evidence? Pharmacogenetics, Pharmacokinetics, and Pharmacodynamics
Abstract
The Food and Drug Administration (FDA) reviewed 300 new drug applications between 1995 and 2000. Of the 163 that included a sex analysis, 11 drugs showed a >40% difference in pharmacokinetics between males and females, which was listed on the product label, yet no dosing recommendations were made based on sex. Female sex has been shown to be a risk factor for clinically relevant adverse drug reactions. Would simply dosing females based on their different pharmacokinetics decrease the incidence of adverse events? The answer is not known. Sex-dependent pharmacodynamic effects have been identified. The role of pharmacokinetics vs. pharmacodynamics is unclear, as is the impact of pharmacogenetics on both. This review highlights a few specific examples in each area in which sex differences in pharmacokinetics and pharmacodynamics are important and provides recommendations for additional needed research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785
Frezza, M., di Padova, C., Pozzato, G., Terpin, M., Baraona, E., & Lieber, C. S. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001113220205 · Cited by 1,328
Mackenzie, P. I., Owens, I. S., Burchell, B., Bock, K. W., Bairoch, A., Belanger, A., Gigleux, S. F., Green, M., Hum, D. W., Iyanagi, T., et al. (1997) · Pharmacogenetics · doi:10.1097/00008571-199708000-00001 · Cited by 1,183
Identification of functionally variant MDR1 alleles among European Americans and African Americans
Kim, R. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.117412 · Cited by 1,009
Genetic contribution to variable human CYP3A-mediated metabolism
Lamba, J. K., Lin, Y. S., Schuetz, E. G., & Thummel, K. E. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00066-2 · Cited by 990
Female Gender as a Risk Factor for Torsades de Pointes Associated With Cardiovascular Drugs
Makkar, R. R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510210076031 · Cited by 971
The Human Hepatic Cytochromes P450 Involved in Drug Metabolism
Wrighton, S. A., & Stevens, J. C. (1992) · Critical Reviews in Toxicology · doi:10.3109/10408449209145319 · Cited by 944
Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
Desta, Z., Zhao, X., Shin, J.-G., & Flockhart, D. A. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241120-00002 · Cited by 942
Cytochrome P4502C9: an enzyme of major importance in human drug metabolism
Miners, J. O., & Birkett, D. J. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00721.x · Cited by 844
Changes in plasma protein binding have little clinical relevance
Benet, L. Z., & Hoener, B. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.121829 · Cited by 825
Association of Serum Digoxin Concentration and Outcomes in Patients With Heart Failure
Rathore, S. S., Curtis, J. P., Wang, Y., Bristow, M. R., & Krumholz, H. M. (2003) · JAMA · doi:10.1001/jama.289.7.871 · Cited by 772
Bertz, R. J., & Granneman, G. R. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732030-00004 · Cited by 755
Gender Differences in Treatment Response to Sertraline Versus Imipramine in Chronic Depression
Kornstein, S. G., Schatzberg, A. F., Thase, M. E., Yonkers, K. A., McCullough, J. P., Keitner, G. I., Gelenberg, A. J., Davis, S. M., Harrison, W. M., & Keller, M. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.9.1445 · Cited by 702
Sex-Based Differences in the Effect of Digoxin for the Treatment of Heart Failure
Rathore, S. S., Wang, Y., & Krumholz, H. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021266 · Cited by 690
Olanzapine: Pharmacokinetic and Pharmacodynamic Profile
Callaghan, J. T., Bergstrom, R. F., Ptak, L. R., & Beasley, C. M. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937030-00001 · Cited by 544
Sex Is A Major Determinant of Cyp3a4 Expression in Human Liver
Wolbold, R., Klein, K., Burk, O., Nüssler, A. K., Neuhaus, P., Eichelbaum, M., Schwab, M., & Zanger, U. M. (2003) · Hepatology · doi:10.1002/hep.1840380424 · Cited by 529
Gender Effects in Pharmacokinetics and Pharmacodynamics
Harris, R. Z., Benet, L. Z., & Schwartz, J. B. (1995) · Drugs · doi:10.2165/00003495-199550020-00003 · Cited by 506
The Influence of Sex on Pharmacokinetics
Schwartz, J. B. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342020-00001 · Cited by 467
How Important Are Gender Differences in Pharmacokinetics?
Meibohm, B., Beierle, I., & Derendorf, H. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241050-00002 · Cited by 454
Bertilsson, L. (1995) · Clinical Pharmacokinetics · doi:10.2165/00003088-199529030-00005 · Cited by 432
Lamba, V., Lamba, J., Yasuda, K., Strom, S., Davila, J., Hancock, M. L., Fackenthal, J. D., Rogan, P. K., Ring, B., Wrighton, S. A., et al. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.054866 · Cited by 400
Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations
Alv�n, G., Bechtel, P., Iselius, L., & Gundert-Remy, U. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf00316090 · Cited by 361
Renal hemodynamics and tubular function in normal human pregnancy
Davison, J. M., & Dunlop, W. (1980) · Kidney International · doi:10.1038/ki.1980.124 · Cited by 338
The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia
Mikkelsen, W. M., Dodge, H. J., Valkenburg, H., & Himes, S. (1965) · The American Journal of Medicine · doi:10.1016/0002-9343(65)90048-3 · Cited by 331
Pharmacokinetic Changes During Pregnancy and Their Clinical Relevance
Loebstein, R., Lalkin, A., & Koren, G. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733050-00002 · Cited by 314
Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2* activities
Relling, M. V., Lin, J.-S., Ayers, G. D., & Evans, W. E. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.203 · Cited by 314
Drug-Induced QT Prolongation in Women During the Menstrual Cycle
Rodriguez, I. (2001) · JAMA · doi:10.1001/jama.285.10.1322 · Cited by 311
Wormhoudt, L. W., Commandeur, J. N. M., & Vermeulen, N. P. E. (1999) · Critical Reviews in Toxicology · doi:10.1080/10408449991349186 · Cited by 302
Fattinger, K., Roos, M., Vergères, P., Holenstein, C., Kind, B., Masche, U., Stocker, D. N., Braunschweig, S., Kullak‐Ublick, G. A., Galeazzi, R. L., et al. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00132.x · Cited by 296
High Blood Alcohol Levels in Women
(1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230113 · Cited by 289
Schuetz, E. G., Furuya, K. N., & Schuetz, J. D. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12089-2 · Cited by 265
Clinical Importance of Hepatic Cytochrome P450 in Drug Metabolism
Spatzenegger, M., & Jaeger, W. (1995) · Drug Metabolism Reviews · doi:10.3109/03602539508998329 · Cited by 245
Lamotrigine clearance during pregnancy
Tran, T. A., Leppik, I. E., Blesi, K., Sathanandan, S. T., & Remmel, R. (2002) · Neurology · doi:10.1212/wnl.59.2.251 · Cited by 241
Is Gender a Risk Factor for Adverse Drug Reactions?: The Example of Drug-Induced Long QT Syndrome
Drici, M.-D., & Cl??ment, N. (2001) · Drug Safety · doi:10.2165/00002018-200124080-00002 · Cited by 226
Induction of CYP2D6 in pregnancy*
Wadelius, M., Darj, E., Frenne, G., & Rane, A. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90118-1 · Cited by 226
Specificity of human UDP-Glucuronosyltransferases and xenobiotic glucuronidation
Burchell, B., Brierley, C. H., & Rance, D. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02073-r · Cited by 224
The impact of pregnancy and childbirth on the metabolism of lamotrigine
Pennell, P. B., Newport, D. J., Stowe, Z. N., Helmers, S. L., Montgomery, J. Q., & Henry, T. R. (2004) · Neurology · doi:10.1212/01.wnl.0000103286.47129.f8 · Cited by 223
Gender Differences in Adverse Drug Reactions
Tran, C., Knowles, S. R., Liu, B. A., & Shear, N. H. (1998) · The Journal of Clinical Pharmacology · doi:10.1177/009127009803801103 · Cited by 217
Mateos Antón, F., García Puig, J., Ramos, T., González, P., & Ordás, J. (1986) · Metabolism · doi:10.1016/0026-0495(86)90152-6 · Cited by 211
Antiepileptic drug pharmacokinetics during pregnancy and lactation
Pennell, P. B. (2003) · Neurology · doi:10.1212/wnl.61.6_suppl_2.s35 · Cited by 211
Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation
Heikkinen, T. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(02)17634-x · Cited by 209
Effects of age and gender on in vitro properties of human liver microsomal monooxygenases
Schmucker, D. L., Woodhouse, K. W., Wang, R. K., Wynne, H., James, O. F., McManus, M., & Kremers, P. (1990) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1990.164 · Cited by 207
Pharmacogenetics of cytochrome P4502D6: genetic background and clinical implication
Cascorbi, I. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.33.s2.3.x · Cited by 206
Bock, K. W., Schrenk, D., Forster, A., Griese, E.-U., M??rike, K., Brockmeier, D., & Eichelbaum, M. (1994) · Pharmacogenetics · doi:10.1097/00008571-199408000-00005 · Cited by 199
Xie, H.-G., Stein, C. M., Kim, R. B., Wilkinson, G. R., Flockhart, D. A., & Wood, A. J. J. (1999) · Pharmacogenetics · doi:10.1097/00008571-199910000-00001 · Cited by 181
Clinical relevance of genetic polymorphisms in the human CYP2C9 gene
Schwarz, U. I. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.33.s2.6.x · Cited by 170
Lee, S.-J., Usmani, K. A., Chanas, B., Ghanayem, B., Xi, T., Hodgson, E., Mohrenweiser, H. W., & Goldstein, J. A. (2003) · Pharmacogenetics · doi:10.1097/00008571-200308000-00004 · Cited by 167
Cummins, C. L., Wu, C., & Benet, L. Z. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.128388 · Cited by 166
Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers
Hagg, S., Spigset, O., & Dahlqvist, R. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2001.01328.x · Cited by 164
Tomson, T., Lindbom, U., Ekqvist, B., & Sundqvist, A. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb02921.x · Cited by 161
Lane, H.-Y., Chang, Y.-C., Chang, W.-H., Lin, S.-K., Tseng, Y.-T., & Jann, M. W. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0108 · Cited by 158
le Lucas, D., nez, C. M., Girre, C., Berthou, F. O., nez, P. B., Joannet, I., Hispard, É., Bardou, L., & nez, J.-F. O. M. (1995) · Pharmacogenetics · doi:10.1097/00008571-199510000-00005 · Cited by 150
Liu, X. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00673-9 · Cited by 150
Greater quinidine-induced QTc interval prolongation in women
Benton, R. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.105761 · Cited by 148
Body Weight and Risk of Oral Contraceptive Failure
Holt, V. L., Cushing‐Haugen, K. L., & Daling, J. R. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)01939-7 · Cited by 147
Vancomycin Pharmacokinetics in a Patient Population
Ducharme, M. P., Slaughter, R. L., & Edwards, D. J. (1994) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199410000-00013 · Cited by 146
Hormonal regulation of organic cation transporter OCT2 expression in rat kidney
Urakami, Y., Okuda, M., Saito, H., & Inui, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01525-8 · Cited by 145
Tamminga, W. J., Wemer, J., Oosterhuis, B., Wieling, J., Wilffert, B., de Leij, L. F. M. H., de Zeeuw, R. A., & Jonkman, J. H. G. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050615 · Cited by 144
Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil
McGready, R. M., Stepniewska, K., Seaton, E. D., Cho, T., Cho, D., Ginsberg, A., Edstein, M. D., Ashley, E. A., Looareesuwan, S., White, N. J., et al. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0651-x · Cited by 140
Gender Differences in the Membrane Transport of Endogenous and Exogenous Compounds
Morris, M. E., Lee, H., & Predko, L. M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.1 · Cited by 140
Serum protein binding of drugs during and after pregnancy in humans
Dean, M. E., Stock, B. H., Patterson, R. J., & Levy, G. (1980) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1980.158 · Cited by 139
The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria
McGready, R., Stepniewska, K., Edstein, M. D., Cho, T., Gilveray, G., Looareesuwan, S., White, N. J., & Nosten, F. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0652-9 · Cited by 138
Gender as a Risk Factor for Adverse Events to Medications
Kando, J. C., Yonkers, K. A., & Cole, J. O. (1995) · Drugs · doi:10.2165/00003495-199550010-00001 · Cited by 128
Pharmacokinetics of anticonvulsants in pregnancy: Alterations in plasma protein binding
Yerby, M. S., Friel, P. N., McCormick, K. B., Koerner, M., Allen, M. I. V., Leavitt, A., Sells, C. J., & Yerby, J. A. (1990) · Epilepsy Research · doi:10.1016/0920-1211(90)90042-t · Cited by 127
Pregnancy-induced increase in metoprolol metabolism
Högstedt, S., LINDBERG, B. S., Peng, D.-R., Regårdh, C. G., & Rane, A. (1985) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1985.114 · Cited by 124
Tsutsumi, K. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.116495 · Cited by 124
Diazepam Kinetics in Relation to Age and Sex
Ochs, H. R., Greenblatt, D. J., Divoll, M., Abernethy, D. R., Feyerabend, H., & Dengler, H. J. (2008) · Pharmacology · doi:10.1159/000137524 · Cited by 114
The Uridine Diphosphate Glucuronosyltransferase Multigene Family: Function and Regulation
Clarke, D. J., & Burchell, B. (1994) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-78429-3_1 · Cited by 114
Chen, M. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.111184 · Cited by 113
Anthony, M., & Berg, M. J. (2002) · Journal of Women s Health & Gender-Based Medicine · doi:10.1089/152460902760360559 · Cited by 107
Tannergren, C. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00238-8 · Cited by 88
Effect of food on the absorption of enteric-coated aspirin: Correlation with gastric residence time
Mojaverian, P., Rocci, M. L., Conner, D. P., Abrams, W. B., & Vlasses, P. H. (1987) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1987.3 · Cited by 85
Rasmussen, B. B., & Brøsen, K. (1996) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199606000-00006 · Cited by 80
The Underestimated Long Term Medical and Economic Consequences of Rheumatoid Arthritis
Pincus, T. (1995) · Drugs · doi:10.2165/00003495-199500501-00003 · Cited by 79
Management of Cardiac Arrhythmias during Pregnancy
Rotmensch, H. H., Rotmensch, S., & Elkayam, U. (1987) · Drugs · doi:10.2165/00003495-198733060-00005 · Cited by 69
Anthony, M., & Berg, M. J. (2002) · Journal of Women s Health & Gender-Based Medicine · doi:10.1089/152460902760360568 · Cited by 67
Gaudry, S. E., SITAR, D. S., Smyth, D. D., McKenzie, J. K., & Aoki, F. Y. (1993) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1993.104 · Cited by 66
Pharmacokinetics of nelfinavir and indinavir in HIV-1-infected pregnant women
Kosel, B. W., Beckerman, K., Hayashi, S., Homma, M., & Aweeka, F. T. (2003) · AIDS · doi:10.1097/00002030-200305230-00011 · Cited by 66
Aging of women alters S-verapamil pharmacokinetics and pharmacodynamics
Schwartz, J. B., Capili, H., & Daugherty, J. (1994) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1994.64 · Cited by 61
Anderson, G. D. (2002) · PubMed · Cited by 56
Self-citationYukawa, E., Mine, H., Higuchi, S., & Aoyama, T. (1992) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1992.tb05515.x · Cited by 55
Phenotypic-genotypic analysis of CYP2C19 in the Jewish Israeli population
Sviri, S., Shpizen, S., LEITERSDORF, E., et al. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70106-2 · Cited by 53
Effects of age and gender on pharmacokinetics of cefepime
Barbhaiya, R. H., Knupp, C. A., & Pittman, K. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.6.1181 · Cited by 49
WEDEL, M., PIETERS, J. E., Pikaar, N. A., & Ockhuizen, T. (1991) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a045119 · Cited by 46
Longitudinal effects of pregnancy on the pharmacokinetics of theophylline
Gardner, M. J., Schatz, M. X., Cousins, L., Zeiger, R. S., Middleton, E., & Jusko, W. J. (1987) · European Journal of Clinical Pharmacology · doi:10.1007/bf00607577 · Cited by 45
Genetic polymorphism of S-mephenytoin 4??-hydroxylation in African-Americans
Edeki, T. I., Goldstein, J. A., de Morais, S. M. F., et al. (1996) · Pharmacogenetics · doi:10.1097/00008571-199608000-00009 · Cited by 45
Effect of age and sex on glomerular filtration rate measured by 51Cr-EDTA.
Gross, J. L., Friedman, R., de Azevedo, M. J., Silveiro, S. P., & Pecis, M. (1992) · PubMed · Cited by 44
Jennings, T. S., Nafziger, A. N., Davidson, L. K., & Bertino, J. (1993) · PubMed · Cited by 28
Disposition of alprazolam in human volunteers. Differences between genders.
Kristjánsson, F., & Thorsteinsson, S. B. (1991) · PubMed · Cited by 27
Plasma concentration ? effect relationship of metoprolol during and after pregnancy
H�gstedt, S., & Rane, A. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00271365 · Cited by 21
Population Pharmacokinetics of Continuous Infusion Ceftazidime
Frame, B. C., Facca, B., Nicolau, D. P., & Triesenberg, S. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937040-00005 · Cited by 21
Pharmacokinetic and Pharmacodynamic Evaluation of Atenolol during and after Pregnancy
Hurst, A. K., Shotan, A., Hoffman, K., Johnson, J. K., Goodwin, T. M., Koda, R. T., & Elkayam, U. (1998) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1998.tb03906.x · Cited by 19
Reigner, B. G., & Welker, H. A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.3.575 · Cited by 10
Cited by
Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes
Waxman, D. J., & Holloway, M. G. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.056705 · Cited by 815
The impact of sex on gene expression across human tissues
Oliva, M., Muñoz-Aguirre, M., Kim-Hellmuth, S., Wucher, V., Gewirtz, A. D. H., Cotter, D. J., Parsana, P., Kasela, S., Balliu, B., Viñuela, A., et al. (2020) · Science · doi:10.1126/science.aba3066 · Cited by 670
Sex and gender differences in health: Science & Society Series on Sex and Science
Regitz‐Zagrosek, V. (2012) · The EMBO Reports · doi:10.1038/embor.2012.87 · Cited by 572
Growth Hormone Regulation of Sex-Dependent Liver Gene Expression
Waxman, D. J., & O’Connor, C. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0007 · Cited by 458
Gender differences in drug responses
FRANCONI, F., BRUNELLESCHI, S., STEARDO, L., & CUOMO, V (2007) · Pharmacological Research · doi:10.1016/j.phrs.2006.11.001 · Cited by 454
Metadata
- Authors
- Anderson, G. D.
- Venue
- Journal of Women's Health
- Publisher
- SAGE Publications
- Published
- 2005-01
- Volume
- 14
- Issue
- 1
- Pages
- 19-29
- ISSN
- 1059-7115 (ISSN-L)
- 1540-9996
- 1931-843X
- OpenAlex
- W1968825227
- Cited by
- 321
- References
- 93
- FWCI
- 12.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.